Clinical Summary: High Care Ward Management

Share

Summary

An overview of the patient's clinical status and ongoing care plan for life-threatening anaemia and haemodynamic instability.

Clinical Summary: High Care Ward Management

Highlights

Clinical Status (24/07/2026 – 30/07/2026)

The patient remains in the High Care Ward due to life-threatening anaemia and persistent hypotension. Clinical symptoms include severe fatigue, poor appetite, nausea, vomiting, and abdominal discomfort. The patient requires continuous haemodynamic monitoring, oxygen therapy, and insulin management for elevated blood glucose levels. Due to ongoing fragility, the patient is currently unsuitable for transfer to a lower level of care.

Treatment Plan and Monitoring

The care plan includes continuous cardiac and hourly vital sign monitoring, 2-hourly blood glucose management, and strict fluid balance monitoring. Pharmacological interventions include IV Pantocid, IV Emistop, and chronic medications. The team is managing pain and antiemetics while continuing neurophysiotherapy. Laboratory investigations and blood transfusions are performed as needed, with daily medical reviews to determine future transfer suitability.

Vital Signs and Clinical Data

Key vital signs recorded show hypotension (BP 88/52–96/60 mmHg), tachycardia (HR 94–104 bpm), and a haemoglobin level of 8.1 g/dL. Oxygen saturation is maintained between 93–95% on nasal oxygen, and glucose levels (HGT) are managed between 7.9–9.2 mmol/L. The patient currently has a Waterloo score of 16 and a request for an additional 15 days of high-care ward stay.

Recently Summarized Articles

Loading...